StonvexLoading…
StonvexStonvexStonvexCore line items from VRTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.28B | $2.99B | $12.00B | $8.81B | $5.73B |
Operating Income | Not available | $1.14B | $4.17B | $2.97B | $1.78B |
Net Income | Not available | $1.03B | $3.95B | $2.76B | $1.68B |
EPS (Diluted) | $4.82 | $4.02 | $15.32 | $10.68 | $6.48 |
Total Assets | Not available | $26.48B | $25.64B | $24.86B | $24.04B |
Total Liabilities | Not available | $7.12B | $6.98B | $7.54B | $6.86B |
Cash & Equivalents | Not available | $5.49B | $5.08B | $4.94B | $4.97B |
Free Cash Flow OCF − CapEx | Not available | $1.29B | $3.19B | $2.85B | $1.71B |
Shares Outstanding | Not available | 254.16M | 253.99M | 253.95M | 256.29M |